Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Peloruside A: a lead non-taxoid-site microtubule-stabilizing agent with potential activity against cancer, neurodegeneration, and autoimmune disease.
Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors.
Cytoskeletal Linker Protein Dystonin Is Not Critical to Terminal Oligodendrocyte Differentiation or CNS Myelination.
The Clinical Features and Diagnosis of Adrenoleukodystrophy: A Case Series of Iranian Family.
Hypoxia-inducible factor 1 in autoimmune diseases.
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
Enhancing our understanding of white matter changes in early multiple sclerosis.
[Current and historical concept of neuromyelitis optica].
What do we know about brain contrast enhancement patterns in neuromyelitis optica?
The adaptive immune response in celiac disease.
A blood based 12-miRNA signature of Alzheimer disease patients.
Erratum: Genomic analysis of ERVWE2 locus in patients with Multiple sclerosis: absence of genetic association but potential role of Human Endogenous retrovirus type W elements in molecular mimicry with myelin antigen.
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules.
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
Occupational Therapy Interventions for Adults With Multiple Sclerosis.
Vitamin D in the healthy and inflamed central nervous system: access and function.
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Omega-3 Fatty Acids for Depression in Multiple Sclerosis: A Randomized Pilot Study.
Long-term motor, cognitive and behavioral outcome of acute disseminated encephalomyelitis.
Viral vectors for therapy of neurologic diseases.
Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels.

Pages